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2Overview
 Genome-wide association study
 Ontology fingerprints
 Using ontology fingerprints to quantify the
relationship between genes and
disease/phenotypes/traits
 Ontology fingerprints derived gene networks
to identify polygenic model for diseases
3Genome-wide Association
Study
4GWA Studies In Action
5What is a GWA Study?
 A genome-wide association study is an approach
that involves rapidly scanning markers across the
complete sets of DNA, or genomes, of many people
to find genetic variations associated with a particular
disease. Once new genetic associations are
identified, researchers can use the information to
develop better strategies to detect, treat and prevent
the disease. Such studies are particularly useful in
finding genetic variations that contribute to common,
complex diseases, such as asthma, cancer,
diabetes, heart disease and mental illnesses
6What is a GWA Study?
 Method for interrogating all 10 million variable
points across human genome
 Variation inherited in groups, or blocks, so
not all 10 million points have to be tested
7Linkage Disequilibrium Blocks Can Have
Many Genes
8
9Genome Wide Association Study for LDL,
HDL and TG
 16876 individuals
 Clinical observations considered – Height,
weight, BMI, LDL, HDL and TG level etc
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Genome Wide Association Study for LDL,
HDL and TG
 Identify genes that falls into the loci that are
significantly associated with phenotype
 HDL – 237 genes from top 201 LD blocks
 LDL --  212 genes from top 199 LD blocks
 TG --  221 genes from top 200 LD blocks
 Challenge – Which genes are more relevant?
Gene Disease
Comprehensive
Quantitative
?
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Ontology Fingerprints
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Biomedical Ontology
 Many ontologies have been developed:
 Gene Ontology
 Cell Ontology
 Foundation Model of Anatomy
 Disease Ontology
 …
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Annotation of Apolipoprotein A-4
Gene annotation by Gene Ontology has been used
extensively by microarray data analysis.
To assess the relevance of genes to the disease of
interest, we need a quantitative measure.
14
Our Approach
 Text mining approach to identify ontology
terms enriched in the PubMed Abstracts that
relevant to a particular gene or disease to
generate an ontology finger prints
 Assess how similar it is between the ontology
fingerprints of a gene and a disease
 Rank identify genes based on the similarity of
their ontology fingerprints to disease for
GWAS
15
Hypergeometric Test
# Abstracts
Relevant to a
Gene
# Abstracts
Irrelevant to a
Gene
Abstracts with
a specific term
Abstracts without 
a specific term
Total
X K-X                    K
M-X            N-K+X    M+N-K
16
Hypergeometric Test
17
Basic Idea – when research
papers are published about a
gene, what ontology terms they
talk about the most?
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Ontology Fingerprint
 A set of ontology terms overrepresented in
the PubMed abstracts linked to a gene or a
disease along with these terms’
corresponding enrichment p-values
 A comprehensive characterization of genes
and diseases
19
Ontology Fingerprints after p-value
Adjustment
GO id GO term Raw p-value Adjusted p-value
GO:0016298 Lipase activity 8 x 10
-22
9 x 10
-22
GO:0004091 Carboxylesterase activity 5 x 10
-21
6 x 10
-21
GO:0042627 Chylomicron 4 x 10
-16
4 x 10
-16
... … … …
GO:0007610 Behavior 6 x 10
-2
8 x 10
-2
GO:0003708 Retinoic acid receptor activity 6 x 10
-2
9 x 10
-2
... … … …
GO:0044464 Cell part 9 x 10
-1 1
GO:0004871 Signal transducer activity 9 x 10
-1 1
>Apolipoprotein C-II, APOC2
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Ontology Fingerprints for HDL
 >PATH#HDL
 GO#GO_0033344 1e-323       cholesterol efflux
 GO#GO_0016298 1e-323 lipase activity
 …
 GO#GO_0030301 1e-323 cholesterol transport
 GO#GO_0015918 1e-323 sterol transport
 GO#GO_0005323 1e-323 very-low-density lipoprotein
 GO#GO_0005322 1e-323 low-density lipoprotein
 GO#GO_0005321 1e-323 high-density lipoprotein
 ….
 GO#GO_0006810   1.54742e-310    transport
 GO#GO_0051234   2.16484e-296    establishment of localization
 GO#GO_0030228   7.60472e-248    lipoprotein receptor activity
 GO#GO_0042697   4.32514e-243    menopause
21
Can we really use ontology
fingerprints to identify genes
relevant to a
trait/phenotype/disease?
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Comparing Ontology Fingerprints
>ATP-binding cassette, sub-family A, member 1 ( ABCA1 )
GO#GO_0030301 1.87E-122 CHOLESTEROL TRANSPORT
GO#GO_0005215 4.89E-117 TRANSPORTER
GO#GO_0033344 2.42E-114 CHOLESTEROL EFFLUX
GO#GO_0006810 7.89E-93 TRANSPORT
GO#GO_0005320 7.01E-80 APOLIPOPROTEIN
GO#GO_0051234 7.73E-75 ESTABLISHMENT OF LOCALIZATION
>HDL
GO#GO_0033344 0 cholesterol efflux 
… … …
GO#GO_0030301 0 cholesterol transport 
GO#GO_0015918 0 sterol transport 
….
GO#GO_0006810 1.54E-310 transport 
GO#GO_0051234 2.16E-296 establishment of localization 
23
Comparing Ontology Fingerprints
24
Relevance between a gene and a
pathway can be quantified
Gene name Gene symbol Similarity Score
Mitogen-activated protein kinase 1 MAPK1 481.8
BCL2-antagonist of cell death BAD 194.76
Serum response factor SRF 260.07
Vascular endothelial growth factor A VEGFA 2341.19
Caspase 9, apoptosis-related cysteine peptidase CASP9 370.94
Splicing factor proline/glutamine-rich SFPQ 13.82
EP300 interacting inhibitor of differentiation 2B EID2B 1.67
Ring finger and CCCH-type zinc finger domains 1 RC3H2 0
Stathmin-like 4 STMN4 0.72
Sperm flagellar 1 SPEF1 0.18
Kegg Genes
Non-Kegg Genes
Prostate Cancer Pathway
25
Validation – Using Ontology Fingerprints
to Identify Pathways a Gene Belongs to?
 10 different KEGG pathways
 For each pathway, identify human genes
belong to the pathway – positive control
 Identify 3 pathways specific to bacterial
 For each bacterial pathway, identify bacterial
genes that has no homolog in human –
negative control
 Use ontology fingerprints for genes and
pathways to pair genes with pathways
26
Area Under Curve for Ten pathways
Pathway 
Ontology Fingerprint 
AUC
Anni 2.0 AUC
Apoptosis 0.96 0.85*
Biosynthesis of steroids 0.75 0.73
Fatty acid metabolism 0.88 0.86
Focal Adhesion 0.94 0.87*
Galactose metabolism 0.90 0.78*
Glycolysis 0.80 0.72*
MAP kinase signaling pathway 0.90 0.78*
Prostate cancer 0.95 0.91*
Renal cell carcinoma 0.93 0.81*
Sphingolipid metabolism 0.89 0.72*
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Receiver Operating Characteristic (ROC)
Curves for Four Pathways
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Gene Id Score Annotation
4023 9808.26 lipoprotein lipase
19 9741.04 ATP-binding cassette, sub-family A (ABC1), member 1
348 6772.21 apolipoprotein E
3949 4332.74 low density lipoprotein receptor (familial hypercholesterolemia)
338 3973.8 apolipoprotein B (including Ag(x) antigen)
Genes Ranked for HDL
29
Gene Id Score Annotation
4023 9808.26 lipoprotein lipase
19 9741.04 ATP-binding cassette, sub-family A (ABC1), member 1
348 6772.21 apolipoprotein E
3949 4332.74 low density lipoprotein receptor (familial hypercholesterolemia)
338 3973.8 apolipoprotein B (including Ag(x) antigen)
1071 2830.4 cholesteryl ester transfer protein, plasma
3990 2725.8 lipase, hepatic
5465 2380.38 peroxisome proliferator-activated receptor alpha
344 1950.58 apolipoprotein C-II
4036 1615.41 low density lipoprotein-related protein 2
4043 1443.38 low density lipoprotein receptor-related protein associated protein 1
7520 1358.5 X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80kDa)
1742 1145.05 discs, large homolog 4 (Drosophila)
4089 1142.52 SMAD family member 4
5371 1103.41 promyelocytic leukemia
7068 1092.12 thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)
1356 1085.79 ceruloplasmin (ferroxidase)
116519 1084.99 apolipoprotein A-V
3569 1061.43 interleukin 6 (interferon, beta 2)
64240 986.802 ATP-binding cassette, sub-family G (WHITE), member 5 (sterolin 1)
2113 887.013 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
64241 877.776 ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2)
7253 829.328 thyroid stimulating hormone receptor
6564 827.674 solute carrier family 15 (oligopeptide transporter), member 1
3146 773.341 high-mobility group box 1
2237 728.375 flap structure-specific endonuclease 1
341 721.345 apolipoprotein C-I
6678 693.686 secreted protein, acidic, cysteine-rich (osteonectin)
1600 686.358 disabled homolog 1 (Drosophila)
255738 639.314 proprotein convertase subtilisin/kexin type 9
Genes Ranked for HDL
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Transferrin and Lipid Metabolism
31
Gene GO Term GO Id
Cholesterol efflux GO:0033344
Transporter activity GO:0005215
Reverse cholesterol transport GO:0043691 
Lipoprotein lipase activity GO:0004465 
chylomicron GO:0042627 
Lipid transport GO:0006869 
Reverse cholesterol transport GO:0043691 
Lipoprotein lipase activity GO:0004465 
Cholesterol efflux GO:0033344
Low-density lipoprotein receptor activity GO:0005041 
endocytosis GO:0006897
Cell surface GO:0009986 
Low-density lipoprotein receptor activity GO:0005041 
Cholesterol transport GO:0030301 
Lipoproteinlipase activity GO:0004465 
Lipoprotein receptor activity GO:0030228 
chylomicron GO:0042627 
Lipoprotein lipase activity GO:0004465 
Lipoprotein lipase activity GO:0004465 
chylomicron GO:0042627 
digestion GO:0007586 
Lipoprotein lipase activity GO:0004465 
chylomicron GO:0042627 
peroxisome GO:0005777 
Lipoprotein lipase activity GO:0004465 
Lipoprotein receptor activity GO:0030228 
Low-density lipoprotein binding GO:0030169 
HDL
ATP-binding cassette, sub-family A, member 1 ( ABCA1 )
Lipoprotein lipase ( LPL )
Cholesteryl ester transfer protein, plasma ( CETP )
LDL
LDL recepor ( LDLR )
Apolipoprotein E ( APOE )
Apolipoprotein B ( APOB )
Triglyceride
Lipoprotein lipase ( LPL )
Apolipoprotein A-V ( APOA5 )
Low density lipoprotein-related protein 2 ( LRP2 )
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Prioritize Genes with Similar p-value from
Genome-wide Association Study
Trait Gene Best SNP Best P-value Similarity Score
ABCA1 rs2000069 2.25 x 10
-5
1133.75
PEX5 rs10770616 2.29 x 10
-5
118.982
LGALS1 rs739139 2.24 x 10
-5
48.3371
GNAO1 rs4783937 7.86 x 10
-5
112.176
SLC36A2 rs10050758 7.89 x 10
-5
4.64188
TRPC6 rs4466798 1.01 x 10
-4
129.288
AXUD1 rs17735402 1.02 x 10
-4
0
LDL
LDL
TG
33
Linkage Disequilibrium Blocks Can Have
Many Genes
34
Chromosome Position
5465 PPARA 211.493
150383 LOC150383 0
1071 CETP 1473.99
9709 HERPUD1 0
6559 SLC12A3 67.2739
9709 HERPUD1 0
348 APOE 2824.46
341 APOC1 296.763
5819 PVRL2 95.7221
10452 TOMM40 8.03323
344 APOC2 543.665
341 APOC1 296.763
346 APOC4 60.6262
3956 LGALS1 48.3371
57026 PDXP 0.12471
79159 MGC3731 0
116519 APOA5 795.062
8882 ZNF259 0.213755
84811 BUD13 0
27329 ANGPTL3 56.8199
85440 DOCK7 0
chr11 116168917
chr1 62756485
50087106
chr19 50124397
chr22 36391511
Gene Id Gene Similarity Score
chr22 44953108
HDL
LDL
TG
LD Block
Phenotype
chr16 55542264
chr16 55500422
chr19
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Ontology fingerprints derived
gene networks to identify
polygenic models for diseases
37
Ontology fingerprints derived gene
network to dissect complex diseases
 Many diseases are caused by variants in multiple
genes
 Each variant may only marginally associated with a
disease phenotype, but collectively the relevant
variants have very significant association
 Genes in a polygenic model are likely involved in
relevant biological functions
But
 Enormous amount of possible combinations among
variants are hard to test
 Need efficient algorithm to narrow down candidate
polygenic models
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Construct a Gene Network Based on the
Similarity of Genes’ Ontology Fingerprints
39
Identify polygenic disease model from
gene network
40
Polygenic model for dyslipidemia
41
Conclusion
 Ontology fingerprints constructed from enriched
ontology terms in the PubMed abstracts can
characterize genes and diseases
 By comparing ontology fingerprints of two biological
concepts, we can quantify the relevance between
them
 Quantified relevance can be used to prioritize genes
from genome-wide association study
 Gene networks can be derived from comparing the
ontology fingerprints of genes, and polygenic
disease model can be identified as network modules
42
Future works, challenges and wish list
 Future works
 Identify more genes and ontology terms from PubMed
abstracts
 Use full text and expand to other ontology
 Relevance between genes and clinical concepts
 Gene networks and models
 Challenges
 Availability of ontology terms and full text papers
 Relationship of ontology terms
 Wish list
 Full text accurately annotated with genes and ontology terms
 High quality ontology that covers extensive biological domains
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